Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia

被引:48
|
作者
Segman, RH
Goltser, T
Heresco-Levy, U
Finkel, B
Shalem, R
Schlafman, M
Yakir, A
Greenberg, D
Strous, R
Lerner, A
Shelevoy, A
Lerer, B
机构
[1] Hadassah Hebrew Univ Med Ctr, Dept Psychiat, Biol Psychiat Lab, IL-91120 Jerusalem, Israel
[2] Herzog Hosp, Jerusalem, Israel
[3] Lev Hasharon Hosp, Pardessia, Israel
[4] Kfar Shaul Hosp, Jerusalem, Israel
[5] Beer Yaakov Mental Hlth Ctr, Beer Yaagov, Israel
来源
PHARMACOGENOMICS JOURNAL | 2003年 / 3卷 / 05期
关键词
tardive dyskinesia; dopamine; serotonin; genetic association;
D O I
10.1038/sj.tpj.6500194
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Tardive dyskinesia (TD) is a long-term adverse effect of antipsychotic drugs that are dopamine D2 receptor blockers. Serotonin receptor antagonism has been proposed as a common mechanism contributing to the low extrapyramidal side effect profile of atypical antipsychotic drugs. We evaluated candidate dopamine and serotonin genes for association with drug-induced TD. We examined three polymorphisms in the dopamine D2 receptor gene (DRD2), two sites in the 30 region of the dopamine transporter (DAT) gene, two sites in the promoter and coding region of the dopamine D4 (DRD4) receptor gene, as well as polymorphic sites in the serotonin 6 receptor gene, the serotonin transporter gene and the tryptophan hydroxylase gene, for association with TD susceptibility. Schizophrenic patients with (n = 59) and without TD (n = 63), matched for antipsychotic drug exposure and other relevant variables, were studied. No significant associations were found. Within the limitations imposed by the size of the clinical sample, these findings suggest that the above polymorphic loci do not contribute significantly to risk for TD. Further examination of loci that yielded positive results at a trend level and investigation of other candidate genetic loci coding for antipsychotic drug targets is warranted.
引用
收藏
页码:277 / 283
页数:7
相关论文
共 50 条
  • [1] Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia
    R H Segman
    T Goltser
    U Heresco-Levy
    B Finkel
    R Shalem
    M Schlafman
    A Yakir
    D Greenberg
    R Strous
    A Lerner
    A Shelevoy
    B Lerer
    [J]. The Pharmacogenomics Journal, 2003, 3 : 277 - 283
  • [2] Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia
    Fedorenko, Olga Yu
    Paderina, Diana Z.
    Kornetova, Elena G.
    Poltavskaya, Evgeniya G.
    Pozhidaev, Ivan, V
    Goncharova, Anastasiia A.
    Freidin, Maxim B.
    Bocharova, Anna, V
    Bokhan, Nikolay A.
    Loonen, Anton J. M.
    Ivanova, Svetlana A.
    [J]. DIAGNOSTICS, 2022, 12 (07)
  • [3] Smoking and tardive dyskinesia in male patients with chronic schizophrenia
    Zhang, Xiang Yang
    Yu, Ya Qin
    Sun, Shilong
    Zhang, Xuan
    Li, Wenjun
    Xiu, Mei Hong
    Chen, Da Chun
    Yang, Fu De
    Zhu, Fengyan
    Kosten, Therese A.
    Kosten, Thomas R.
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (07): : 1765 - 1769
  • [4] Treatment Outcomes of Patients With Tardive Dyskinesia and Chronic Schizophrenia
    Caroff, Stanley N.
    Davis, Vicki G.
    Miller, Del D.
    Davis, Sonia M.
    Rosenheck, Robert A.
    McEvoy, Joseph P.
    Campbell, E. Cabrina
    Saltz, Bruce L.
    Riggio, Silvana
    Chakos, Miranda H.
    Swartz, Marvin S.
    Keefe, Richard S. E.
    Stroup, T. Scott
    Lieberman, Jeffrey A.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (03) : 295 - 303
  • [5] Evidence for Association of the GLI2 Gene with Tardive Dyskinesia in Patients with Chronic Schizophrenia
    Greenbaum, Lior
    Alkelai, Anna
    Rigbi, Amihai
    Kohn, Yoav
    Lerer, Bernard
    [J]. MOVEMENT DISORDERS, 2010, 25 (16) : 2809 - 2817
  • [6] Sex difference in association between tardive dyskinesia and cognitive deficits in patients with chronic schizophrenia
    Zhang, Wanni
    Wang, Dongmei
    Zhou, Huixia
    Chen, Dachun
    Xiu, Meihong
    Cui, Lixia
    Zhang, Xiangyang
    [J]. SCHIZOPHRENIA RESEARCH, 2023, 255 : 140 - 147
  • [7] Polymorphisms of μ and δ opioid receptor genes and tardive dyskinesia in patients with schizophrenia
    Ohmori, O
    Shinkai, T
    Hori, H
    Kojima, H
    Nakamura, J
    [J]. SCHIZOPHRENIA RESEARCH, 2001, 52 (1-2) : 137 - 138
  • [8] Smoking and tardive dyskinesia in patients with schizophrenia
    Zouari, L.
    Smaoui, N.
    Abida, I.
    Charfi, N.
    Maalej, M.
    Zouari, N.
    Ben Thabet, J.
    Maalej, M.
    [J]. EUROPEAN PSYCHIATRY, 2017, 41 : S391 - S392
  • [9] Tardive dyskinesia in Chinese inpatients with chronic schizophrenia
    Leung, SK
    Ungvari, GS
    Ng, FS
    Cheung, HK
    Leung, T
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (06): : 1029 - 1035
  • [10] No Association between PAWR Gene Polymorphisms and Tardive Dyskinesia in Schizophrenia Patients
    Kim, Il-Soo
    Yoon, Ho-Kyoung
    Kang, Seung-Gul
    Park, Young-Min
    Kim, Yong-Ku
    Kim, Seung-Hyun
    Choi, Jung-Eun
    Kim, Leen
    Lee, Heon-Jeong
    [J]. PSYCHIATRY INVESTIGATION, 2012, 9 (02) : 191 - 194